Treatment of H. pylori infection;Traitement de l'infection a Helicobacter pylori

Revue du Praticien

Volumn 50, Issue 13, 2000, Pages 1442-1445

  Lamouliatte, H ^a   Cayla, R ^a   Megraud, F ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; DOSE TIME EFFECT RELATION; DRUG INDUCED DISEASE; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PATIENT COMPLIANCE; REVIEW; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PENICILLINS; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0034283084     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Conference de consensus: Maladie ulcereuse et gastrites a l'heure d'Helicobacter pylori
2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
3. Traitement des gastrites chroniques associees a Campylobacter pylori
4. Comment eradiquer Helicobacter pylori? Conference de consensus 1995
5. Current european concepts in the management of Helicobacter pylori Infection. The Maastricht consensus report
6. Comment eradiquer Helicobacter pylori
7. Dual therapy versus triple therapy for H. pylori eradication. Preliminary results of a randomized controlled trial
8. Short-term low dose therapy for the eradication of H. pylori
9. Eradication of H. pylori using one week triple therapies combining omeprazole with two antibiotics
10. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin and clarithromycin to eradicate Helicobacter pylori infection: Results of a prospective randomized open study
11. Evaluation of shortterm ranitidine versus omeprazole triple therapy regimen for eradication of H. pylori in duodenal ulcer patients
12. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of H. pylori in patients with non-ulcer dyspepsia: Influence of dosage of omeprazole and clarithromycin
13. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia
14. Helicobacter pylori eradication with a one week triple therapy: Meta-analysis of french studies
15. Traitement de l'infection par helicobacter pylori par lansoprazole 30 mg ou 60 mg associe a deux antibiotiques chez les ulcereux duodenaux
16. Randomized comparison of different periods of twice-a-day triple therapy for the eradication of H. pylori
17. Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H. pylori infection?
18. Facteurs d'echec de l'eradication de Helicobacter pylori dans les essais cliniques multicentriques menes en France
19. Cag A negative status: A risk factor for failure of H. pylori triple therapies in non-ulcer dyspepsia
20. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: A key factor of treatment failure
21. Survey of the in vitro susceptibility of H. pylori to antibiotics in France. Preliminary results
22. Clinical relevance of resistant strains of H. pylori: A review of current data
23. Primary and acquired H. pylori resistance to clarithromycin, metronidazole amoxicillin. Influence on treatment outcome
24. Influence de la resistance primaire a la clarithromycine sur l'efficacite de la tritherapie amoxicilline-clarithromycine-IPP pour eradiquer H. pylori et prevalence des resistances a la clarithromycine et au metronidazole en cas d'echec
25. Comment gerer les echecs du traitement eradicateur de Helicobacter pylori
26. Nitazoxanide, a potential drug for eradication of H. pylori with no cross-resistance to metronidazole
27. Treatment with quadruple therapy after triple therapy failure in patients infected with H. pylori resistant strains